Chlamydia trachomatis inhibits inducible NO synthase in human mesenchymal stem cells by stimulating polyamine synthesis

Journal of Immunology

Volumn 193, Issue 6, 2014, Pages 2941-2951

  Abu Lubad, Mohammad ^a   Meyer, Thomas F ^a   Al Zeer, Munir A ^a  

^a MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; ORNITHINE DECARBOXYLASE; PEROXYNITRITE; POLYAMINE; ARGININE; EFLORNITHINE; ENZYME INHIBITOR; MESSENGER RNA; ORNITHINE DECARBOXYLASE INHIBITOR; PEROXYNITROUS ACID; SMALL INTERFERING RNA;

ARTICLE; BACTERIAL GROWTH; BACTERIAL SURVIVAL; CELLULAR IMMUNITY; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INNATE IMMUNITY; MESENCHYMAL STEM CELL; NEWBORN; NITRATION; NONHUMAN; POLYAMINE SYNTHESIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS REGULATION; RNA INTERFERENCE; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL CULTURE; CHEMISTRY; CHLAMYDIASIS; ENZYMOLOGY; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; MESENCHYMAL STROMA CELL; METABOLISM; MICROBIOLOGY; UPREGULATION;

ARGININE; CELLS, CULTURED; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; EFLORNITHINE; ENZYME INHIBITORS; FEMALE; HUMANS; MESENCHYMAL STROMAL CELLS; NITRIC OXIDE SYNTHASE TYPE II; ORNITHINE DECARBOXYLASE; ORNITHINE DECARBOXYLASE INHIBITORS; PEROXYNITROUS ACID; POLYAMINES; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; UP-REGULATION;

EID: 84907083338     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400377     Document Type: Article

References (72)

1. Burillo, A., and E. Bouza. 2010. Chlamydophila pneumoniae. Infect. Dis. Clin. North Am. 24: 61-71
2. Hammerschlag, M. R. 2004. Chlamydia trachomatis and Chlamydia pneumoniae infections in children and adolescents. Pediatr. Rev. 25: 43-51
3. Abdelrahman, Y. M., and R. J. Belland. 2005. The chlamydial developmental cycle. FEMS Microbiol. Rev. 29: 949-959
4. Wyrick, P. B. 2000. Intracellular survival by Chlamydia. Cell. Microbiol. 2: 275-282
5. Ouellette , S. P., F. C. Dorsey, S. Moshiach, J. L. Cleveland, and R. A. Carabeo. 2011. Chlamydia species-dependent differences in the growth requirement for lysosomes. PLoS ONE 6: e16783
6. Fan, T., H. Lu , H. Hu, L. Shi, G. A. McClarty, D. M. Nance, A. H. Greenberg, and G. Zhong. 1998. Inhibition of apoptosis in chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation. J. Exp. Med. 187: 487-496
7. Zhong, G., L. Liu, T. Fan, P. Fan, and H. Ji. 2000. Degradation of transcription factor RFX5 during the inhibition of both constitutive and interferon gammainducible major histocompa tibility complex class I expression in chlamydiainfected cells J. Exp. Med. 191: 1525-1534
8. Byrne, G. I., and D. M. Ojcius. 2004. Chlamydia and apoptosis: life and death decisions of an intracellular pathogen. Nat. Rev. Microbiol. 2: 802-808
9. Fields, K. A., and T. Hackstadt. 2002. The chlamydial inclusion: escape from the endocytic pathway. Annu. Rev. Cell Dev. Biol. 18: 221-245
10. Rottenberg, M. E., A. Gigliotti-Rothfuchs, and H. Wigzell. 2002. The role of IFNgamma in the outcome of chlamydial infection. Curr. Opin. Immunol. 14: 444-451
11. Grisham, M. B., D. N. G ranger, and D. J. Lefer. 1998. Modulation of leukocyteendothelial interactions by reactive metabolites of oxygen and nitrogen: relevance to ischemic heart disease. Free Radic. Biol. Med. 25: 404-433
12. Hier holzer, C., B. Harbrecht, J. M. Menezes, J. Kane, J. MacMicking, C. F. Nathan, A. B. Peitzman, T. R. Billiar, and D. J. Tweardy. 1998. Essential role of induced nitric oxide in the initiation of the inflammatory res ponse after hemorrhagic shock. J. Exp. Med. 187: 917-928
13. Nathan, H. C., C. J. Bacchi, S. H. Hutner, D. Rescigno, P. P. McCann, and A. Sjoerdsma. 1981. Antagonism by polyamines of the cura tive effects of alphadifluoromethylornithine in Trypanosoma brucei brucei infections. Biochem. Pharmacol. 30: 3010-3013
14. Pacher, P., J. S. Beckman, and L. Liaudet. 2007. Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 87: 315-424
15. MacMicking, J., Q. W. Xie, and C. Nathan. 1997. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15: 323-350
16. Nathan, C., and M. U. Shiloh. 2000. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc. Natl. Acad. Sci. USA 97: 8841-8848
17. Zaki, M. H., T. Akuta, and T. Akaike. 2005. Nitric oxide-induced nitrative stress involved in microbial pathogenesis. J. Pharmacol. Sci. 98: 117-129.
18. Carratelli C. R.,A. Rizzo,R. Paolillo,M. R. Catania,P. Catalanotti,F. Rossano, 2005, Effect of nitric oxide on the growth of Chlamydophila pneumoniae. Can. J. Microbiol, 51, 941-947.
19. Mayer, B., B. Heinzel, P. Klatt , M. John, K. Schmidt, and E. Bö hme. 1992. Nitric oxide synthase-catalyzed activation of oxygen and reduction of cytochromes: reaction mechanisms and possible physiological implications. J. Cardiovasc. Pharmacol. 20(Suppl 12): S54-S56
20. Chen, B., R. Stout, and W. F. Campbell. 1996. Nitric oxide production: a mechanism of Chlamydia trachomatis inhibition in interferon-gamma-treated RAW264.7 cells. FEMS Immunol. Med. Microbiol. 14: 109-120
21. Igietseme, J. U., I. M. Uriri, M. Chow, E. Abe, and R. G. Rank. 1997. Inhibition of intracellular multiplication of human strains of Chlamydia trachomatis by nitric oxide. Biochem. Bio phys. Res. Commun. 232: 595-601
22. Igietseme, J. U., I. M. Uriri, R. Hawkins, and R. G. Rank. 1996. Integrinmediated epithelial-T cell interaction enhances nitric oxide production and increased intracellular inhibition of Chlamydia. J. Leukoc. Biol. 59: 656-662
23. Igietseme, J. U., L. L. Perry, G. A. Ananaba, I. M. Uriri, O. O. Ojior, S. N. Kumar, and H. D. Caldwell. 1998. Chlamydial infection in inducible nitric oxide synthase knockout mice. Infect. Immun. 66: 1282-1286
24. Ramsey, K. H., G. S. Miranpuri, C. E. Poulsen, N. B. Marthakis, L. M. Braune, and G. I. Byrne. 1998. Inducible nitric oxide synthase does not affect resolution of murine chlamydial genital tract infections or eradication of chlamydiae in primary murine cell culture. Infect. Immun. 66: 835-838
25. Johnson, R. M., M. S. Kerr, and J. E. Slaven. 2012. Plac8-dependent and inducible NO synthase-dependent mechanisms clear Chlamydia muridarum infections from the genital tract. J. Immunol. 188: 1896 -1904
26. Jazedje, T., P. M. Perin, C. E. Czeresnia, M. Maluf, S. Halpern, M. Secco, D. F. Bueno, N. M. Vieira, E. Zucconi, and M. Zatz. 2009. Human fallopian tube: a new source of multipotent adult mesenchymal stem cells discarded in surgical procedures. J. Transl. Med. 7:46
27. Al-Zeer, M. A., H. M. Al-Younes, D. Lauster, M. Abu Lubad, and T. F. Meyer. 2013. Autophagy restricts Chlamydia trachomatis growth in human macrophages via IFNG-inducible guanylate binding proteins. Autophagy 9: 50-62
28. Zhang, C., T. W. Hein, W. Wang, M. W. Miller, T. W. Fossum, M. M. McDonald, J. D. Humphrey, and L. Kuo. 2004. Upregulation of vascular arginase in hypertension decreases nitric oxide-mediated dilation of coronary arterioles. Hype rtension 44: 935-943
29. Munder, M., K. Eichmann, J. M. Morán, F. Centeno, G. Soler, and M. Modolell. 1999. Th1/Th2-regulated expression of arginase isoforms in murine macrophages and dendri tic cells. J. Immunol. 163: 3771-3777
30. Gilbert, R. S., G. G. Gonzalez, L. Hawel III, and C. V. Byus. 1991. An ionexchange chromatography procedure for the isolation and concentration of basic amino acids and polyamines from complex biological samples prior to highperformance liquid chromatography. Anal. Biochem. 199: 86-92
31. Brückner, H., and M. Lüpke. 1995. Use of chromogenic and fluorescent oxycarbonyl chlorides as reagents for amino acid analysis by high-performance liquid chromatography. J. Chromatogr. A 697: 295-307
32. Chan, R. W., K. E. Schwab, and C. E. Gargett. 2004. Clonogenicity of human endometrial epithelial and stromal cells. Biol. Reprod. 70: 1738-1750
33. Gargett, C. E. 2007. Uterine stem cells: what is the evidence? Hum. Reprod. Update 13: 87-101
34. Patel, A. N., E. Park, M. Kuzman, F. Benetti, F. J. Silva, and J. G. Allickson. 2008. Multipotent menstrual blood stromal stem cells: isolation, characterization, and differentiation. Cell Transplant. 17: 303-311
35. Morrison, R. P., and H. D. Caldwell. 2002. Immunity to murine chlamydial genital infe ction. Infect. Immun. 70: 2741-2751
36. Chaturvedi, R., M. Asim, S. Hoge, N. D. Lewis, K. Singh, D. P. Barry, T. de Sablet, M. B. Piazuelo, A. R. Sarvaria, Y. Cheng, E. I. Closs, R. A. Casero, Jr., A. P. Gobert, and K. T. Wilson. 2010. Polyamines impair immunity to Helicobacter pylori by inhibiting L-arginine uptake required for nitric oxide production. Gastroenterology. 139: 1686-1698
37. Chaturvedi, R., T. de Sablet, L. A. Coburn, A. P. Gobert, and K. T. Wilson. 2012. Arginine and polyamines in Helicobacter pylori-induced immune dysregulation and gastric carcinogenesis. Amino Acids 42: 627-640
38. Lahiri, A., P. Das, and D. Chakravortty. 2008. Arginase modulates Salmonella induced nitric oxide production in RAW264.7 macrophages and is required for Salmonella pathogenesis in mice model of infection. Microbes Infect. 10: 1166-1174.
39. Lewis N.D.,M. Asim,D.P. Barry,K. Singh,T. De Sablet,J.L. Boucher,A.P. Gobert,R. Chaturvedi,K.T. Wilson, 2010, Arginase II re stricts host defense to Helicobacter pylori by attenuating inducible nitric oxide synthase translation in macrophages, J. Immunol, 184, 2572-2582.
40. Barry, D. P., M. Asim, D. A. Leiman, T. de Sablet, K. Singh, R. A. Casero, Jr., R. Chaturvedi, and K. T. Wilson. 2011. Difluoromethylornithine is a novel inhibitor of Helicobacter pylori growth, CagA translocation, and interleukin-8 induction. PLoS ONE 6: e17510
41. Beatty, W. L., G. I. Byrne, and R. P. Morrison. 1993. Morphologic and antigenic characterization of interferon gamma-mediated persistent Chlamydia trachomatis infection in vitro. Proc. Natl. Acad. Sci. USA 90: 3998-4002
42. Kojima, H., Y. Urano, K. Kikuchi, T. Higuchi, Y. Hirata, and T. Nagano. 1999. Fluorescent indicators for imaging nitric oxide production. Angew. Chem. Int. Ed. Engl. 38: 3209-3212
43. Alam, M. S., T. Akaike, S. Okamoto, T. Kubota, J. Yoshitake, T. Sawa, Y. Miyamoto, F. Tamura, and H. Maeda. 2002. Role of nitric oxide in host defense in murine salmonellosis as a function of its antibacterial and antiapoptotic activities. Infect. Immun. 70: 3130-3142.
44. Gérard, H. C., J. A. Whittum-Hudson, J. D. Cater, and A. P. Hudson. 2004. Differential expression of three Chlamydia trachomatis Hsp60-encoding genes in acute vs persistence infections. Microb. Pathog. 36: 35-39
45. Bussière, F. I., R. Chaturvedi, Y. Cheng, A. P. Gobert, M. Asim, D. R. Blumberg, H. Xu, P. Y. Kim, A. Hacker, R. A. Casero, Jr., and K. T. Wilson. 2005. Spermine causes loss of innate immune response to Helicobacter pylori by inhibition o f inducible nitric-oxide synthase translation. J. Biol. Chem. 280: 2409-2412
46. Bogdan, C., M. Rö llinghoff, and A. Diefenbach. 2000. The role of nitric oxide in innate immunity. Immunol. Rev. 173: 17-26
47. Roshick, C., H. Wood, H. D. Caldwell, and G. McClarty. 2006. Comparison of gamma interferon-mediated antichlamydial defense mechanisms in human and mouse cells. Infect. Immun. 74: 225-238
48. Agrawal, T., A. R. Bhengraj, V. Vats, S. Salhan, and A. Mittal. 2011. Expression of TLR 2, TLR 4 and iNOS in cervical monocytes of Chlamydia trachomatisinfected women and their role in host immune resp onse. Am. J. Reprod. Immunol. 66: 534-543
49. Wu, G., and S. M. Morris, Jr. 1998. Arginine metabolism: nitric oxide and beyond. Biochem. J. 336: 1-17
50. Ouzounis, C. A., and N. C. Kyrpides. 1994. On the evolution of arginases and related enzymes. J. Mol. Evol. 39: 101-104
51. Igarashi, K., and K. Kashiwagi. 2000. Polyamines: mysterious modulators of cellula r functions. Biochem. Biophys. Res. Commun. 271: 559-564
52. Cuervo, H., M. A. Pineda, M. P. Aoki, S. Gea, M. Fresno, and N. Gironès. 2008. Inducible nitric oxide synthase and arginase expressio n in heart tissue during acute Trypanosoma cruzi infection in mice: arginase I is expressed in infiltrating CD68+ macrophages. J. Infect. Dis. 197: 1772-1782
53. Talaue, M. T., V. Venketaraman, M. H. Hazbón, M. Peteroy-Kelly, A. Seth, R. Colangeli, D. Alland, and N. D. Connell. 2006. Arginine homeostasis in J774.1 macrophages in the context of Mycobacterium bovis BCG infection. J. Bacteriol. 188: 4830-4840
54. Das, P., A. Lahiri, A. Lahiri, and D. Chakravortty. 2010. Modulation of the arginase pathway in the context of microbial pathogenesis: a metabolic enzyme moonlighting as an immune modulator. PLoS Pathog. 6: e1000899
55. Boitz, J. M., P. A. Yates, C. Kline, U. Gaur, M. E. Wilson, B. Ullman, and S. C. Roberts. 2009. Leishmania donovani ornithine decarboxylase is indispensable for parasite survival in the mammalia n host. Infect. Immun. 77: 756-763
56. Gilroy, C., T. Olenyik, S. C. Roberts, and B. Ullman. 2011. Spermidine synthase is required for virulence of Leishmania donovani. Infect. Immun. 79: 2764-2769
57. Pfaff, A. W., O. Villard, J. P. Klein, M. Mousli, and E. Candolfi. 2005. Regulation of Toxoplasma gondii multiplication in BeWo trophoblast cells: crossregulation of nitric oxide production and po lyamine biosynthesis. Int. J. Parasitol. 35: 1569-1576
58. Kropf, P., J. M. Fuentes, E. Fähnrich, L. Arpa, S. Herath, V. Weber, G. Soler, A. Celada, M. Modolell, and I. Müller. 2005. Arginase and polyamine synthesis are key factors in the regulation of experimental leishmaniasis in vivo. FASEB J. 19: 1000-1002
59. Kaur, K., K. Emmett, P. P. McCann, A. Sjoerdsma, and B. Ullman. 1986. Effects of DL-alpha-difluoromethylornithine on Leishmania donovani promastigotes. J. Protozool. 33: 518-521.
60. Gradoni L.,Iorio M.A.,M. Gramiccia,S. Orsini, 1989, In vivo effect of eflornithine (DFMO) and some related compounds on Leishmania infantum preliminary communication, Farmaco, 44, 1157-1166.
61. Szabo, C., G. J. Sowthan, C. Thiemermann, and J. R. Vane. 1994. The mechanism of the inhibitory effect of polyamines on the induction of NOS: role of aldehyde metabolites. Br. J. Pharmacol. 113: 757-766
62. Lee, J., H. Ryu, R. J. Ferrante, S. M. Morris, Jr., and R. R. Ratan. 2003. Translational control of inducible nitric oxide synthase expression by arginine can explain the arginine paradox. Proc. Natl. Acad. Sci. USA 100: 4843-4848
63. El-Gayar, S., H. Thüring-Nahler, J. Pfeilschifter, M. Röllinghoff, and C. Bogdan. 2003. Translational control of inducible nitric oxide synthase by IL-13 and arginine availability in inflammatory macrophages. J. Immunol. 171: 4561-4568
64. Hö gbom, M., P. Stenmark, N. Voevodskaya, G. McClarty, A. Gräslund, and P. Nordlund. 2004. The radical site in chlamydial ribonucleotide reductase defines a new R2 subclass. Science 305: 245-248
65. Matsushima, H., M. Shirai, K. Ouchi, K. Yamashita, T. Kakutani, S. Furukawa, and T. Nakazawa. 1999. Lymphotoxin inhibits Chlamydia pneumoniae growth in HEp-2 cells. Infect. Immun. 67: 3175-3179
66. Nathan, C. 1997. Inducible nitric oxide synthase: what difference does it make? J. Clin. Invest. 100: 2417-2423
67. Bartesaghi, S., G. Ferrer-Sueta, G. Peluffo, V. Valez, H. Zhang, B. Kalyanaraman, and R. Radi. 2007. Protein tyrosine nitration in hydrophilic and hydrophobic environments. Amino Acids 32: 501-515
68. Genevaux, P., C. Georgopoulos, and W. L. Kelley. 2007. The Hsp70 chaperone machines of Escherichia coli: a paradigm for the repartition of chaperone functions. Mol. Microbiol. 66: 840-857
69. Ranford, J. C., A. R. Coates, and B. Henderson. 2000. Chaperonins are cellsignalling proteins: the unfolding biology of molecular chaperones. Expert Rev. Mol. Med. 2: 1-17
70. Konkel, M. E., B. J. Kim, J. D. Klena, C. R. Young, and R. Ziprin. 1998. Characterization of the thermal stress response of Campylobacter jejuni. Infect. Immun. 66: 3666-3672
71. Takaya, A., T. Tomoyasu, H. Matsui, and T. Yamamoto. 2004. The DnaK/DnaJ chaperone machinery of Salmonella enterica serovar Typhimurium is essential for invasion of epithelial cells and survival wit hin macrophages, leading to systemic infection. Infect. Immun. 72: 1364-1373
72. Rouquette, C., C. de Chastellier, S. Nair, and P. Berche. 1998. The ClpC ATPase of Listeria mon ocytogenes is a general stress protein required for virulence and promoting early bacterial escape from the phagosome of macrophages. Mol. Microbiol. 27: 1235-1245